Claim OwnershipEureka!
Subscribed: 9Played: 4
Subscribe
© 2026 McKinsey & Company
Description
McKinsey colleagues Alex Devereson and Nav Nagra explore cutting-edge technology trends, tackle pressing industry challenges, and uncover R&D innovations with biopharma leaders. Whether you're a seasoned professional or a curious enthusiast, this series offers valuable insights and thought-provoking discussions that will keep you informed and inspired. Tune in and stay ahead of the curve in the ever-evolving world of biopharma.
11 Episodes
Reverse
Novartis’s chief data and digital officer for biomedical research explains how data platform investments are paying off in AI safety prediction, generative chemistry, and faster translationSee www.mckinsey.com/privacy-policy for privacy information
Bob Li, AstraZeneca's Senior Vice President, Global Head of Medical Affairs, Oncology, on why only seven percent of cancer patients get access to clinical trials, and what decentralized trials, AI, and international collaboration could do to change that within a decade. See www.mckinsey.com/privacy-policy for privacy information
McKinsey partner Fangning Zhang discusses what’s driving China’s acceleration in drug discovery, why intense competition is fueling speed and cost efficiency, and what global R&D leaders need to do to build a genuine China strategy.See www.mckinsey.com/privacy-policy for privacy information
Bayer’s Senior Vice President and Head of Data Science and AI, Sai Jasti, on how the company is transforming its workflows and embedding AI in research and development to meet ambitious productivity goals.See www.mckinsey.com/privacy-policy for privacy information
Greg Meyers, Executive Vice President and Chief Digital & Technology Officer at Bristol Myers Squibb (BMS) discusses how technology can be leveraged to drive outcomes.See www.mckinsey.com/privacy-policy for privacy information
Comments
Download from Google Play
Download from App Store
United States